{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T04:08:09Z","timestamp":1742011689320,"version":"3.38.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T00:00:00Z","timestamp":1735862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T00:00:00Z","timestamp":1735862400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Comp. Appl. Math."],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s40314-024-03060-3","type":"journal-article","created":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T16:54:58Z","timestamp":1735923298000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A mathematical model to the melanoma dynamics involving CAR T-cells"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7113-8937","authenticated-orcid":false,"given":"Guilherme","family":"Rodrigues","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5285-5591","authenticated-orcid":false,"given":"Jairo G.","family":"Silva","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2732-3830","authenticated-orcid":false,"given":"Mostafa","family":"Adimy","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2080-8053","authenticated-orcid":false,"given":"Paulo F. A.","family":"Mancera","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,1,3]]},"reference":[{"key":"3060_CR1","unstructured":"Ambahera S (2022) Mathematical analysis of ordinary differential equations (ODE) and fractional order differential equation (FODE) models of CD70 CAR T-cell therapy for gliomas. PhD thesis, Middle Tennessee State University"},{"key":"3060_CR2","unstructured":"American\u00a0Cancer Society (2024) Key statistics for melanoma skin cancer. Online. https:\/\/www.cancer.org\/cancer\/types\/melanoma-skin-cancer\/about\/key-statistics.html. Accessed 21 Feb 2024"},{"issue":"5","key":"3060_CR3","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1001\/jamadermatol.2022.0160","volume":"158","author":"M Arnold","year":"2022","unstructured":"Arnold M, Singh D, Laversanne M, Vignat J, Vaccarella S, Meheus F, Cust AE, de Vries E, Whiteman DC, Bray F (2022) Global burden of cutaneous melanoma in 2020 and projections to 2040. JAMA Dermatol 158(5):495\u2013503. https:\/\/doi.org\/10.1001\/jamadermatol.2022.0160","journal-title":"JAMA Dermatol"},{"key":"3060_CR4","doi-asserted-by":"publisher","unstructured":"Barros LRC, de Jesus\u00a0Rodrigues B, Almeida RC (2020) Car-T cell goes on a mathematical model. J Cell Immunol 2(1):31\u201337. https:\/\/doi.org\/10.33696\/immunology.2.016","DOI":"10.33696\/immunology.2.016"},{"issue":"12","key":"3060_CR5","doi-asserted-by":"publisher","first-page":"2941","DOI":"10.3390\/cancers13122941","volume":"13","author":"LRC Barros","year":"2021","unstructured":"Barros LRC, Paix\u00e3o EA, Valli AMP, Naozuka GT, Fassoni AC, Almeida RC (2021) CARTmath\u2014a mathematical model of CAR-T immunotherapy in preclinical studies of hematological cancers. Cancers 13(12):2941. https:\/\/doi.org\/10.3390\/cancers13122941","journal-title":"Cancers"},{"issue":"22","key":"3060_CR6","doi-asserted-by":"publisher","first-page":"3626","DOI":"10.3390\/cells11223626","volume":"11","author":"A Cheever","year":"2022","unstructured":"Cheever A, Townsend M, O\u2019Neill K (2022) Tumor microenvironment immunosuppression: a roadblock to CAR T-cell advancement in solid tumors. Cells 11(22):3626. https:\/\/doi.org\/10.3390\/cells11223626","journal-title":"Cells"},{"issue":"23","key":"3060_CR7","doi-asserted-by":"publisher","first-page":"7230","DOI":"10.1158\/1078-0432.CCR-11-1354","volume":"17","author":"P Chen","year":"2011","unstructured":"Chen P, Huang Y, Bong R, Ding Y, Song N, Wang X, Song X, Luo Y (2011) Tumor-associated macrophages promote angiogenesis and melanoma growth via adrenomedullin in a paracrine and autocrine mannerrole of macrophage-derived adrenomedullin in melanoma. Clin Cancer Res 17(23):7230\u20137239. https:\/\/doi.org\/10.1158\/1078-0432.CCR-11-1354","journal-title":"Clin Cancer Res"},{"key":"3060_CR8","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/s41571-022-00689-z","volume":"19","author":"A Chow","year":"2022","unstructured":"Chow A, Perica K, Klebanoff CA, Wolchok JD (2022) Clinical implications of t cell exhaustion for cancer immunotherapy. Nat Rev Clin Oncol 19:775\u2013790. https:\/\/doi.org\/10.1038\/s41571-022-00689-z","journal-title":"Nat Rev Clin Oncol"},{"issue":"17","key":"3060_CR9","doi-asserted-by":"publisher","first-page":"7950","DOI":"10.1158\/0008-5472.CAN-05-0564","volume":"65","author":"LG de Pillis","year":"2005","unstructured":"de Pillis LG, Radunskaya AE, Wiseman CL (2005) A validated mathematical model of cell-mediated immune response to tumor growth. Cancer Res 65(17):7950\u20137958. https:\/\/doi.org\/10.1158\/0008-5472.CAN-05-0564","journal-title":"Cancer Res"},{"issue":"4","key":"3060_CR10","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.jtbi.2005.06.037","volume":"238","author":"LG de Pillis","year":"2006","unstructured":"de Pillis LG, Gu W, Radunskaya AE (2006) Mixed immunotherapy and chemotherapy of tumors: modeling, applications and biological interpretations. J Theor Biol 238(4):841\u2013862. https:\/\/doi.org\/10.1016\/j.jtbi.2005.06.037","journal-title":"J Theor Biol"},{"issue":"5","key":"3060_CR11","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s10928-014-9386-9","volume":"41","author":"L de Pillis","year":"2014","unstructured":"de Pillis L, Eladdadi A, Radunskaya A (2014) Modeling cancer-immune responses to therapy. J Pharmacokinet Pharmacodyn 41(5):461\u2013478. https:\/\/doi.org\/10.1007\/s10928-014-9386-9","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"3060_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.mbs.2020.108325","volume":"322","author":"R Eftimie","year":"2020","unstructured":"Eftimie R (2020) Investigation into the role of macrophages heterogeneity on solid tumour aggregations. Math Biosci 322:108325. https:\/\/doi.org\/10.1016\/j.mbs.2020.108325","journal-title":"Math Biosci"},{"key":"3060_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtbi.2021.110739","volume":"524","author":"R Eftimie","year":"2021","unstructured":"Eftimie R, Barelle C (2021) Mathematical investigation of innate immune responses to lung cancer: the role of macrophages with mixed phenotypes. J Theor Biol 524:110739. https:\/\/doi.org\/10.1016\/j.jtbi.2021.110739","journal-title":"J Theor Biol"},{"key":"3060_CR14","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jtbi.2017.02.022","volume":"420","author":"R Eftimie","year":"2017","unstructured":"Eftimie R, Hamam H (2017) Modelling and investigation of the CD4+ T cells\u2014macrophages paradox in melanoma immunotherapies. J Theor Biol 420:82\u2013104. https:\/\/doi.org\/10.1016\/j.jtbi.2017.02.022","journal-title":"J Theor Biol"},{"issue":"3","key":"3060_CR15","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.jtbi.2010.04.030","volume":"265","author":"R Eftimie","year":"2010","unstructured":"Eftimie R, Bramson JL, Earn DJD (2010) Modeling anti-tumor Th1 and Th2 immunity in the rejection of melanoma. J Theor Biol 265(3):467\u2013480. https:\/\/doi.org\/10.1016\/j.jtbi.2010.04.030","journal-title":"J Theor Biol"},{"issue":"8","key":"3060_CR16","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1016\/j.bpj.2021.02.017","volume":"120","author":"E Gavagnin","year":"2021","unstructured":"Gavagnin E, Vittadello ST, Gunasingh G, Haass NK, Simpson MJ, Rogers T, Yates CA (2021) Synchronized oscillations in growing cell populations are explained by demographic noise. Biophys J 120(8):1314\u20131322. https:\/\/doi.org\/10.1016\/j.bpj.2021.02.017","journal-title":"Biophys J"},{"issue":"7130","key":"3060_CR17","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/nature05661","volume":"445","author":"V Gray-Schopfer","year":"2007","unstructured":"Gray-Schopfer V, Wellbrock C, Marais R (2007) Melanoma biology and new targeted therapy. Nature 445(7130):851\u2013857. https:\/\/doi.org\/10.1038\/nature05661","journal-title":"Nature"},{"issue":"1","key":"3060_CR18","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","volume":"100","author":"D Hanahan","year":"2000","unstructured":"Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100(1):57\u201370. https:\/\/doi.org\/10.1016\/S0092-8674(00)81683-9","journal-title":"Cell"},{"key":"3060_CR19","doi-asserted-by":"publisher","unstructured":"Herman J, Usher W (2017) SALib: an open-source python library for sensitivity analysis. J Open Source Softw 2(9):2. https:\/\/doi.org\/10.21105\/joss.00097","DOI":"10.21105\/joss.00097"},{"key":"3060_CR20","doi-asserted-by":"publisher","first-page":"18155","DOI":"10.18174\/sesmo.18155","volume":"4","author":"T Iwanaga","year":"2022","unstructured":"Iwanaga T, Usher W, Herman J (2022) Toward SALib 2.0: advancing the accessibility and interpretability of global sensitivity analyses. Socio-Environ Syst Model 4:18155. https:\/\/doi.org\/10.18174\/sesmo.18155","journal-title":"Socio-Environ Syst Model"},{"issue":"2","key":"3060_CR21","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/iub.2543","volume":"74","author":"W-T Kuo","year":"2022","unstructured":"Kuo W-T, Chang JM, Chen CC, Tsao N, Chang C-P (2022) Autophagy drives plasticity and functional polarization of tumor-associated macrophages. Iubmb Life 74(2):157\u2013169. https:\/\/doi.org\/10.1002\/iub.2543","journal-title":"Iubmb Life"},{"issue":"2","key":"3060_CR22","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S0092-8240(05)80260-5","volume":"56","author":"VA Kuznetsov","year":"1994","unstructured":"Kuznetsov VA, Makalkin IA, Taylor MA, Perelson AS (1994) Nonlinear dynamics of immunogenic tumors: parameter estimation and global bifurcation analysis. Bull Math Biol 56(2):295\u2013321. https:\/\/doi.org\/10.1016\/S0092-8240(05)80260-5","journal-title":"Bull Math Biol"},{"issue":"3","key":"3060_CR23","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1084\/jem.161.3.475","volume":"161","author":"SH Lee","year":"1985","unstructured":"Lee SH, Starkey PM, Gordon S (1985) Quantitative analysis of total macrophage content in adult mouse tissues. Immunochemical studies with monoclonal antibody F4\/80. J Exp Med 161(3):475\u2013489. https:\/\/doi.org\/10.1084\/jem.161.3.475","journal-title":"J Exp Med"},{"key":"3060_CR24","doi-asserted-by":"publisher","unstructured":"Le\u00f3n-Triana O, P\u00e9rez-Mart\u00ednez A, Ram\u00edrez-Orellana M, P\u00e9rez-Garc\u00eda VM (2021a) Dual-target CAR-Ts with on-and off-tumour activity may override immune suppression in solid cancers: a mathematical proof of concept. Cancers 13(4):703. https:\/\/doi.org\/10.3390\/cancers13040703","DOI":"10.3390\/cancers13040703"},{"key":"3060_CR25","doi-asserted-by":"publisher","unstructured":"Le\u00f3n-Triana O, Sabir S, Calvo GF, Belmonte-Beitia J, Chuli\u00e1n S, Mart\u00ednez-Rubio \u00c1, Rosa M, P\u00e9rez-Mart\u00ednez A, Ramirez-Orellana M, P\u00e9rez-Garc\u00eda VM (2021b) Car T cell therapy in B-cell acute lymphoblastic leukaemia: insights from mathematical models. Commun Nonlinear Sci Numer Simul 94:105570. https:\/\/doi.org\/10.1016\/j.cnsns.2020.105570","DOI":"10.1016\/j.cnsns.2020.105570"},{"issue":"14","key":"3060_CR26","doi-asserted-by":"publisher","first-page":"6273","DOI":"10.7150\/thno.76854","volume":"12","author":"Z Liu","year":"2022","unstructured":"Liu Z, Zhou Z, Dang Q, Xu H, Lv J, Li H, Han X (2022) Immunosuppression in tumor immune microenvironment and its optimization from CAR-T cell therapy. Theranostics 12(14):6273\u20136290. https:\/\/doi.org\/10.7150\/thno.76854","journal-title":"Theranostics"},{"key":"3060_CR27","unstructured":"M\u00e4kitie T, Summanen P, Tarkkanen A, Kivel\u00e4 T (2001) Tumor-infiltrating macrophages (CD68+ cells) and prognosis in malignant uveal melanoma. Investig Ophthalmol Vis Sci 42(7):1414\u20131421. https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2199967"},{"issue":"7","key":"3060_CR28","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nrclinonc.2016.217","volume":"14","author":"A Mantovani","year":"2017","unstructured":"Mantovani A, Marchesi F, Malesci A, Laghi L, Allavena P (2017) Tumour-associated macrophages as treatment targets in oncology. Nat Rev Clin Oncol 14(7):399\u2013416. https:\/\/doi.org\/10.1038\/nrclinonc.2016.217","journal-title":"Nat Rev Clin Oncol"},{"key":"3060_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109625","volume":"121","author":"E McGowan","year":"2020","unstructured":"McGowan E, Lin Q, Ma G, Yin H, Chen S, Lin Y (2020) PD-1 disrupted CAR-T cells in the treatment of solid tumors: promises and challenges. Biomed Pharmacother 121:109625. https:\/\/doi.org\/10.1016\/j.biopha.2019.109625","journal-title":"Biomed Pharmacother"},{"key":"3060_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.112512","volume":"146","author":"AZ Mehrabadi","year":"2022","unstructured":"Mehrabadi AZ, Ranjbar R, Farzanehpour M, Shahriary A, Dorostkar R, Hamidinejad MA, Ghaleh HEG (2022) Therapeutic potential of CAR T cell in malignancies: a scoping review. Biomed Pharmacother 146:112512. https:\/\/doi.org\/10.1016\/j.biopha.2021.112512","journal-title":"Biomed Pharmacother"},{"key":"3060_CR31","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1155\/2021\/5523055","volume":"2021","author":"SS Mojsilovic","year":"2021","unstructured":"Mojsilovic SS, Mojsilovic S, Villar VH, Santibanez JF (2021) The metabolic features of tumor-associated macrophages: opportunities for immunotherapy? Anal Cell Pathol 2021:12. https:\/\/doi.org\/10.1155\/2021\/5523055","journal-title":"Anal Cell Pathol"},{"key":"3060_CR32","doi-asserted-by":"publisher","unstructured":"Mostolizadeh R, Afsharnezhad Z, Marciniak-Czochra A (2018) Mathematical model of chimeric anti-gene receptor (car) t cell therapy with presence of cytokine. Numer Algebra Control Optim 8(1). https:\/\/doi.org\/10.3934\/naco.2018004","DOI":"10.3934\/naco.2018004"},{"key":"3060_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.cnsns.2020.105684","volume":"96","author":"VM P\u00e9rez-Garc\u00eda","year":"2021","unstructured":"P\u00e9rez-Garc\u00eda VM, Le\u00f3n-Triana O, Rosa M, Perez-Martinez A (2021) CAR T-cells for T-cell leukemias: insights from mathematical models. Commun Nonlinear Sci Numer Simul 96:105684. https:\/\/doi.org\/10.1016\/j.cnsns.2020.105684","journal-title":"Commun Nonlinear Sci Numer Simul"},{"key":"3060_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2022.114421","volume":"188","author":"T Qi","year":"2022","unstructured":"Qi T, McGrath K, Ranganathan R, Dotti G, Cao Y (2022) Cellular kinetics: a clinical and computational review of CAR-T cell pharmacology. Adv Drug Deliv Rev 188:114421. https:\/\/doi.org\/10.1016\/j.addr.2022.114421","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"3060_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-021-20893-2","volume":"12","author":"A Rodriguez-Garcia","year":"2021","unstructured":"Rodriguez-Garcia A, Lynn RC, Poussin M, Eiva MA, Shaw LC, O\u2019Connor RS, Minutolo NG, Casado-Medrano V, Lopez G, Matsuyama T Jr (2021) CAR-T cell-mediated depletion of immunosuppressive tumor-associated macrophages promotes endogenous antitumor immunity and augments adoptive immunotherapy. Nat Commun 12(1):1\u201317. https:\/\/doi.org\/10.1038\/s41467-021-20893-2","journal-title":"Nat Commun"},{"key":"3060_CR36","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s00428-018-2484-0","volume":"474","author":"MW Rohaan","year":"2019","unstructured":"Rohaan MW, Wilgenhof S, Haanen JB (2019) Adoptive cellular therapies: the current landscape. Virchows Arch 474:449\u2013561. https:\/\/doi.org\/10.1007\/s00428-018-2484-0","journal-title":"Virchows Arch"},{"issue":"162","key":"3060_CR37","doi-asserted-by":"publisher","first-page":"20190734","DOI":"10.1098\/rsif.2019.0734","volume":"17","author":"P Sahoo","year":"2020","unstructured":"Sahoo P, Yang X, Abler D, Maestrini D, Adhikarla V, Frankhouser D, Cho H, Machuca V, Wang D, Barish M, Gutova M, Branciamore S, Brown CE, Rockne RC (2020) Mathematical deconvolution of CAR T-cell proliferation and exhaustion from real-time killing assay data. J R Soc Interface 17(162):20190734. https:\/\/doi.org\/10.1098\/rsif.2019.0734","journal-title":"J R Soc Interface"},{"issue":"1","key":"3060_CR38","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1080\/00401706.1999.10485594","volume":"41","author":"A Saltelli","year":"1999","unstructured":"Saltelli A, Tarantola S, Chan KP-S (1999) A quantitative model-independent method for global sensitivity analysis of model output. Technometrics 41(1):39\u201356. https:\/\/doi.org\/10.1080\/00401706.1999.10485594","journal-title":"Technometrics"},{"key":"3060_CR39","volume-title":"Global sensitivity analysis: the primer","author":"A Saltelli","year":"2008","unstructured":"Saltelli A, Ratto M, Andres T, Campolongo F, Cariboni J, Gatelli D, Saisana M, Tarantola S (2008) Global sensitivity analysis: the primer. Wiley, Chichester"},{"key":"3060_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.apm.2023.08.029","volume":"125","author":"DS Santurio","year":"2024","unstructured":"Santurio DS, Paix\u00e3o EA, Barros LR, Almeida RC, Fassoni AC (2024) Mechanisms of resistance to car-t cell immunotherapy: insights from a mathematical model. Appl Math Model 125:1\u201315. https:\/\/doi.org\/10.1016\/j.apm.2023.08.029","journal-title":"Appl Math Model"},{"issue":"2","key":"3060_CR41","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1515\/mr-2021-0014","volume":"1","author":"M Shen","year":"2021","unstructured":"Shen M, Du Y, Ye Y (2021) Tumor-associated macrophages, dendritic cells, and neutrophils: biological roles, crosstalk, and therapeutic relevance. Med Rev 1(2):222\u2013243. https:\/\/doi.org\/10.1515\/mr-2021-0014","journal-title":"Med Rev"},{"key":"3060_CR42","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.apm.2020.06.042","volume":"88","author":"Y Shu","year":"2020","unstructured":"Shu Y, Huang J, Dong Y, Takeuchi Y (2020) Mathematical modeling and bifurcation analysis of pro- and anti-tumor macrophages. Appl Math Model 88:758\u2013773. https:\/\/doi.org\/10.1016\/j.apm.2020.06.042","journal-title":"Appl Math Model"},{"issue":"5","key":"3060_CR43","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.semcancer.2008.03.004","volume":"18","author":"A Sica","year":"2008","unstructured":"Sica A, Larghi P, Mancino A, Rubino L, Porta C, Totaro MG, Rimoldi M, Biswas SK, Allavena P, Mantovani A (2008) Macrophage polarization in tumour progression. Semin Cancer Biol 18(5):349\u2013355. https:\/\/doi.org\/10.1016\/j.semcancer.2008.03.004","journal-title":"Semin Cancer Biol"},{"issue":"12","key":"3060_CR44","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1111\/exd.13792","volume":"27","author":"B Simon","year":"2018","unstructured":"Simon B, Uslu U (2018) CAR T-cell therapy in melanoma: a future success story? Exp Dermatol 27(12):1315\u20131321. https:\/\/doi.org\/10.1111\/exd.13792","journal-title":"Exp Dermatol"},{"issue":"6","key":"3060_CR45","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.3390\/cells10061450","volume":"10","author":"T Soltantoyeh","year":"2021","unstructured":"Soltantoyeh T, Akbari B, Karimi A, Chalbatani GM, Ghahri-Saremi N, Hadjati J, Hamblin MR, Mirzaei HR (2021) Chimeric antigen receptor (CAR) T cell therapy for metastatic melanoma: challenges and road ahead. Cells 10(6):1450. https:\/\/doi.org\/10.3390\/cells10061450","journal-title":"Cells"},{"issue":"1","key":"3060_CR46","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13045-022-01282-8","volume":"15","author":"Y Tie","year":"2022","unstructured":"Tie Y, Tang F, Wei Y-Q, Wei X-W (2022) Immunosuppressive cells in cancer: mechanisms and potential therapeutic targets. J Hematol Oncol 15(1):61. https:\/\/doi.org\/10.1186\/s13045-022-01282-8","journal-title":"J Hematol Oncol"},{"issue":"1","key":"3060_CR47","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.cmet.2019.06.001","volume":"30","author":"I Vitale","year":"2019","unstructured":"Vitale I, Manic G, Coussens LM, Kroemer G, Galluzzi L (2019) Macrophages and metabolism in the tumor microenvironment. Cell Metab 30(1):36\u201350. https:\/\/doi.org\/10.1016\/j.cmet.2019.06.001","journal-title":"Cell Metab"},{"issue":"11","key":"3060_CR48","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1016\/j.apsb.2020.04.004","volume":"10","author":"Q Yang","year":"2020","unstructured":"Yang Q, Guo N, Zhou Y, Chen J, Wei Q, Han M (2020) The role of tumor-associated macrophages (TAMs) in tumor progression and relevant advance in targeted therapy. Acta Pharm Sin B 10(11):2156\u20132170. https:\/\/doi.org\/10.1016\/j.apsb.2020.04.004","journal-title":"Acta Pharm Sin B"},{"issue":"2","key":"3060_CR49","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/psp4.6","volume":"4","author":"X-Y Zhang","year":"2015","unstructured":"Zhang X-Y, Trame MN, Lesko LJ, Schmidt S (2015) Sobol sensitivity analysis: a tool to guide the development and evaluation of systems pharmacology models. CPT Pharmacom Syst Pharmacol 4(2):69\u201379. https:\/\/doi.org\/10.1002\/psp4.6","journal-title":"CPT Pharmacom Syst Pharmacol"},{"key":"3060_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.106036","volume":"175","author":"Z-Z Zhang","year":"2022","unstructured":"Zhang Z-Z, Wang T, Wang X-F, Zhang Y-G, Song S-X, Ma C-G (2022) Improving the ability of CAR-T cells to hit solid tumors: challenges and strategies. Pharmacol Res 175:106036. https:\/\/doi.org\/10.1016\/j.phrs.2021.106036","journal-title":"Pharmacol Res"},{"issue":"4","key":"3060_CR51","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.apsb.2018.03.001","volume":"8","author":"Z Zhao","year":"2018","unstructured":"Zhao Z, Chen Y, Francisco NM, Zhang Y, Wu M (2018) The application of CAR T-cell therapy in hematological malignancies: advantages and challenges. Acta Pharm Sin B 8(4):539\u2013551. https:\/\/doi.org\/10.1016\/j.apsb.2018.03.001","journal-title":"Acta Pharm Sin B"}],"container-title":["Computational and Applied Mathematics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40314-024-03060-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40314-024-03060-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40314-024-03060-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T06:06:19Z","timestamp":1741932379000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40314-024-03060-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,3]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["3060"],"URL":"https:\/\/doi.org\/10.1007\/s40314-024-03060-3","relation":{},"ISSN":["2238-3603","1807-0302"],"issn-type":[{"type":"print","value":"2238-3603"},{"type":"electronic","value":"1807-0302"}],"subject":[],"published":{"date-parts":[[2025,1,3]]},"assertion":[{"value":"20 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there is no conflict\/competing of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publication"}}],"article-number":"101"}}